×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| KREBS BIOCHEMICALS & INDUSTRIE | 117.18 | -77.39 | 114.67 | -3.59 | 182.0 | |
| SYSCHEM (INDIA) LTD. | 911.42 | 5.03 | 911.26 | 0.13 | 179 | |
| BAFNA PHARMACEUTICALS LTD. | 333.77 | 9.48 | 331.88 | 0.40 | 177 | 37.9 |
Krebs Biochemicals & Industries Ltd., with Security Code 524518, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20.9 | 9.0 | 11.4 | 10.5 | 14.8 | 12.9 | 11.9 | 12.8 | 12.8 | 11.4 |
| Expenses | 22.8 | 12.1 | 16.1 | 13.2 | 15.8 | 15.1 | 15.1 | 15.1 | 15.6 | 16.2 |
| Operating Profit | -1.9 | -3.0 | -4.6 | -2.6 | -0.9 | -2.1 | -3.1 | -2.2 | -2.7 | -4.7 |
| OPM % | -9.08% | -32.85% | -40.35% | -24.77% | -6.05% | -16.11% | -26% | -17.04% | -21.08% | -41.13% |
| Other Income | 0.3 | 0.0 | 0.2 | 0.0 | 0.2 | 0.0 | 0.2 | 0.0 | 0.1 | 0.3 |
| Interest | 0.7 | 0.9 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 | 1.3 | 1.4 | 1.6 |
| Depreciation | 1.7 | 1.7 | 1.5 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 |
| Profit before tax | -4.1 | -5.6 | -6.9 | -5.3 | -3.6 | -5.0 | -5.8 | -5.2 | -5.8 | -7.7 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -4.1 | -5.6 | -6.9 | -5.3 | -3.6 | -5.0 | -5.8 | -5.2 | -5.8 | -7.7 |
| EPS in Rs | -1.88 | -2.58 | -3.07 | -2.47 | -1.66 | -2.31 | -2.72 | -2.4 | -2.67 | -3.59 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 1% |
| 3 Years: | -2% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 0% |
| 3 Years: | 9% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -3% |
| 3 Years: | -17% |
| 1 Year: | 17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|